Pregabalin for Alcohol Dependence

• Status: Completed
• Trial end date: 2019-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The study hypothesis is: Pregabalin is superior to placebo in preventing relapse to drinking and reducing drinking severity

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: St. Petersburg Bekhterev Research Psychoneurological Institute
• Collaborator: St.-Petersburg Bekhterev Research Psychoneurological Institute, Russian Federation
• Treatments: Pregabalin

Criteria

Inclusion Criteria:

• Alcohol Dependence by ICD-X criteria

Exclusion Criteria:

• Severe co-morbid psychiatric and somatic diseases